NSUN5 and central nervous system cancer: In gliomas, Nsun5 modifies cytoplasmic RNA through 5-methylcytosine (m5C) modification, which is then oxidized by TET2 into 5-hydroxymethylcytosine (5hmC), leading to RNA degradation and inhibition of tumor growth [29,30,31].